New treatment paradigms for connective tissue disease-associ... : Current Opinion in Pulmonary
Medicine New treatment paradigms for connective tissue disease-associated interstitial lung …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Pulmonary complications are an important extra-articular feature of autoimmune rheumatic
diseases and a major cause of mortality. The underlying pathogenesis probably involves …

Interstitial lung disease is a common pulmonary manifestation of connective tissue diseases
and results in significant morbidity and mortality. Although all connective tissue diseases are …

Systemic sclerosis is an autoimmune connective tissue disorder characterized by fibrosis of
the skin and visceral organs. Interstitial lung disease (ILD) is a major complication of this …

Interstitial lung disease (ILD) can be associated with all connective tissue diseases and is an
important cause of morbidity and mortality. The management of connective tissue disease …

Background: Fibrotic interstitial lung disease is an important driver of morbidity and mortality
in patients with connective tissue diseases (CTD). Due to the lack of prospective randomized …

Recent progress in systemic sclerosis-interstitial lung dise... : Current Opinion in
Rheumatology Recent progress in systemic sclerosis-interstitial lung disease : Current …

The lung is a common site of complications of systemic connective tissue disease (CTD),
and lung involvement can present in several ways. Interstitial lung disease (ILD) and …

Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory
disorders. The development of connective tissue disease-associated interstitial lung disease …